Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.72M Sell
4,884
-19
-0.4% -$6.77K 0.02% 168
2025
Q4
$1.61M Buy
4,903
+165
+3% +$52.3K 0.02% 178
2025
Q3
$1.41M Sell
4,738
-953
-17% -$276K 0.02% 186
2025
Q2
$1.59M Sell
5,691
-190
-3% -$53.8K 0.02% 175
2025
Q1
$1.83M Sell
5,881
-11,396
-66% -$3.37M 0.03% 177
2024
Q4
$4.5M Sell
17,277
-6,012
-26% -$1.78M 0.07% 140
2024
Q3
$7.45M Buy
23,289
+144
+0.6% +$47.1K 0.12% 111
2024
Q2
$7.23M Buy
23,145
+16,825
+266% +$4.94M 0.11% 110
2024
Q1
$1.8M Buy
6,320
+341
+6% +$99.8K 0.04% 176
2023
Q4
$1.72M Sell
5,979
-1,442
-19% -$393K 0.04% 184
2023
Q3
$1.98M Buy
7,421
+686
+10% +$171K 0.05% 180
2023
Q2
$1.5M Sell
6,735
-6,273
-48% -$1.46M 0.04% 208
2023
Q1
$3.14M Sell
13,008
-3,203
-20% -$786K 0.09% 168
2022
Q4
$4.26M Sell
16,211
-7,865
-33% -$2.11M 0.13% 136
2022
Q3
$5.43M Sell
24,076
-38,390
-61% -$9.31M 0.21% 99
2022
Q2
$15.2M Sell
62,466
-14,385
-19% -$3.53M 0.46% 55
2022
Q1
$18.7M Sell
76,851
-17,339
-18% -$3.98M 0.44% 54
2021
Q4
$21.2M Buy
+94,190
New +$19.9M 0.55% 40

Other funds holding AMGN

LGT Group Foundation's AMGN Position: Q1 2026 in Review

LGT Group Foundation reduced its Amgen (AMGN) stake by 0.39% in Q1 2026, selling an estimated $6.77K and leaving 4,884 shares worth $1.72M. The position accounts for 0.02% of the portfolio, ranked #168.

LGT Group Foundation first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $21.2M in Q4 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • LGT Group Foundation held 4,884 shares of Amgen worth $1.72M as of Q1 2026.
  • LGT Group Foundation sold 19 Amgen shares in Q1 2026, an estimated $6.77K.
  • Amgen made up 0.02% of LGT Group Foundation's portfolio in Q1 2026, its #168 holding.
  • LGT Group Foundation first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • LGT Group Foundation's Amgen position peaked at $21.2M in Q4 2021.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.